• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Supernus Pharmaceuticals, Inc. (SUPN)

    -NasdaqGM
    12.13 Up 2.00(19.74%) 4:00PM EST
    |After Hours : 12.13 0.00 (0.00%) 5:33PM EST - Nasdaq Real Time Price
    Prev Close:10.13
    Open:10.08
    Bid:12.10 x 3700
    Ask:12.40 x 300
    1y Target Est:26.14
    Beta:1.15379
    Earnings Date:Mar 1 - Mar 8 (Est.)
    Day's Range:9.51 - 14.59
    52wk Range:8.32 - 23.30
    Volume:4,673,346
    Avg Vol (3m):754,158
    Market Cap:593.44M
    P/E (ttm):48.52
    EPS (ttm):0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SUPN

    Comparison

    Symbol% ChgMkt Cap
    SUPNUp 19.74%593.44M
    JNJDown 3.23%278.19B

    Key Statistics

    Forward P/E (1 yr):15.55
    P/S (ttm):3.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.19
    Quarterly EPS Est (Dec-15) :0.06
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):0.76

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback